Huangshan Capsule (002817.SZ) traded flat 0 % during a 24 hours period ending at 01:19 PM Central Europe on Tuesday 27th. One Huangshan Capsule stock can currently be bought for about CNY 6.15 on popular exchanges. Current supply of Huangshan Capsule stocks is 299.2 mn. Huangshan Capsule has a current market capitalization of CNY 1.9 bn and approximately CNY 33.5 mn worth of Huangshan Capsule was traded on exchanges in the last 24 hours. Since last month end, Huangshan Capsule has traded -5.63 % down. Simple moving average of last 200 days is at CNY 6.43. The highest price of past 52 weeks was recorded at CNY 8.62 on 03/13/2026. 52 weeks low was at CNY 5.53 on 07/21/2026.
Here is how related stocks have performed in the past 24 hours:
Times (001234.SZ) traded flat 0 % and now trades at CNY 20.35. Times has a market capitalisation of CNY 2.3 bn. Current price/earnings ratio for Times is 55.06.
Gospell (002848.SZ) traded flat 0 % and now trades at CNY 13.39. Current market capitalisation for Gospell is CNY 2.3 bn.
Guangdong Anjubao Digital (300155.SZ) traded flat 0 % and now trades at CNY 3.86. Current market capitalisation for Guangdong Anjubao Digital is CNY 2.3 bn. Guangdong Anjubao Digital has reported a shift in its operational focus towards the growing water utilities sector, aligning with broader trends in the global water services market. Analysts note that the company’s emphasis on smart water solutions and integrated supply‑and‑drainage systems is consistent with the positive momentum observed in North American water utilities, which have benefited from increased demand for drinking and wastewater services. The company’s strategic positioning within the water utilities value chain is expected to enhance its market visibility and support long‑term growth prospects. No significant changes in capital structure or dividend policy were disclosed, and the company’s management remains committed to maintaining a steady trajectory of operational efficiency and investment in technological advancement.
Hongxin (301539.SZ) traded flat 0 % and now trades at CNY 14.84. Hongxin has a market capitalisation of CNY 2.3 bn. Hongxin Technology released its third‑quarter 2026 financial results on October 26, reporting a significant increase in revenue across the first nine months of the year, while the company recorded a net loss. Revenue for the full first three quarters rose markedly compared to the previous year, driven primarily by a strong performance in the third quarter. However, the net profit attributable to shareholders fell sharply, with the company reporting a loss that widened relative to the prior year. After excluding non‑recurring items, the loss was even larger, indicating continued pressure on profitability. Management attributed the decline in gross margin to higher average prices for aluminum billets purchased during the period, which impacted overall earnings.
Kontour Medical (688314.SS) traded flat 0 % and now trades at CNY 26.85. Current market capitalisation for Kontour Medical is CNY 2.3 bn. Current price/earnings ratio for Kontour Medical is 29.